AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 90 filers reported holding AVROBIO INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $124,000 | -40.4% | 22,244 | -4.9% | 0.06% | -36.0% |
| Q2 2021 | $208,000 | -26.2% | 23,398 | +5.2% | 0.09% | -27.7% |
| Q1 2021 | $282,000 | -7.5% | 22,244 | +1.8% | 0.12% | -6.3% |
| Q4 2020 | $305,000 | +66.7% | 21,853 | +55.5% | 0.13% | +32.3% |
| Q3 2020 | $183,000 | -34.2% | 14,055 | -11.9% | 0.10% | -27.3% |
| Q2 2020 | $278,000 | +8.6% | 15,955 | -2.9% | 0.13% | +25.7% |
| Q1 2020 | $256,000 | -32.5% | 16,434 | -12.7% | 0.10% | +69.4% |
| Q4 2019 | $379,000 | +44.1% | 18,829 | +0.9% | 0.06% | +17.0% |
| Q3 2019 | $263,000 | -17.8% | 18,656 | -5.3% | 0.05% | -20.9% |
| Q2 2019 | $320,000 | +33.9% | 19,695 | +81.5% | 0.07% | -86.8% |
| Q1 2019 | $239,000 | +17.2% | 10,850 | -11.6% | 0.51% | +1354.3% |
| Q4 2018 | $204,000 | – | 12,277 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |